Breaking Former Carolina Panthers Linebacker Thomas Davis Reveals Opioid Addiction Struggle Nurse Practitioner’s DEA Registration Revoked Amidst Allegations of Illegal Opioid Prescriptions Crown Prince Haakon Ascends to Norwegian Throne as King Haakon VIII Los Angeles Rams Conclude Undefeated Preseason With Victory Over Chargers AI Chatbots Emerge as New Spiritual Guides Amidst Growing Demand

Friday August 28, 2026

Section

Channels

Press Release

Seanergy Maritime Reports Second Quarter and First-Half 2026 Financial Results

Seanergy Maritime Holdings Corp. · Jul 30

Press Release

Lightpath IP Backbone Traffic Grows 32% as Enterprises Adopt AI

Lightpath · Jul 30

Press Release

Executive Coach Mbali Gushu Announces Debut Book Standard Operating Procedures: Life

Pilily · Jul 30

Press Release

Shanghai Amplicon-Gene Bioscience Co., Ltd. Wins “2026 Forbes China Industry Development Innovation Brand” Award

Frost & Sullivan · Jul 30

Press Release

Ebenezer Mortgage Solutions Outlines What Florida’s 2026 Homestead Exemption Amendment Could Mean for Tampa Bay Mortgage Preapprovals

Ebenezer Mortgage Solutions · Jul 30

Press Release

Ontario Ranch, Ontario, and Rancho Cucamonga Real Estate Market Holds Steady Amid Continued New Construction Growth, Q2 2026

Ward & Thomas Group · Jul 30

Press Release

Rolando’s HVAC Explains How Mini-Splits Help Cool Hard-to-Reach Rooms in Tampa Homes

Rolando's H.V.A.C., LLC · Jul 30

Press Release

New Clinical Research Presented at NUTRITION 2026 Shows Superbrewed Food’s Postbiotic Cultured Protein Matches Whey in Muscle-Building Response

Superbrewed Food Inc. · Jul 30

Press Release

AMIRI Selects Intelo.ai to Support In-Season Inventory Decisions Across Its Global Retail Network

Intelo.ai · Jul 30

Press Release

Beauty Creations Lands at CVS Pharmacy, Marking Its Biggest Retail Milestone Yet

Beauty Creations Cosmetics · Jul 30

Press Release

AudioEye Sets Second Quarter 2026 Earnings Call

AudioEye, Inc. · Jul 30

Press Release

Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson’s Disease

Aspen Neuroscience, Inc. · Jul 30

Press Release

Johnson & Johnson’s RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

Johnson & Johnson · Jul 30

← Previous 1 … 3,003 3,004 3,005 … 3,444 Next →